SWKH实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (30 Apr 2024 @ 23:25):

SWK Holdings Corporation, a specialty finance company that focuses on the healthcare sector. It operates in two segments, Finance Receivables and Pharmaceutical Development...

Stats
今日成交量	1 387.00
平均成交量	10 474.00
市值	215.65M
EPS	$0.230 ( 2024-03-20 )
下一个收益日期	( $0 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	13.80
ATR14	$0.0520 (0.30%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Dotter Laurie L.	Buy	815	Common Stock
2024-04-01	Albright Jerry	Buy	815	Common Stock
2024-04-01	Hatcher Robert K.	Buy	815	Common Stock
2024-04-01	Pennington Marcus Edward	Buy	815	Common Stock
2024-04-01	Pennington Marcus Edward	Buy	1 051	Common Stock

INSIDER POWER
-0.88
Last 96 transactions
Buy: 331 841 \| Sell: 586 098

SWK Holdings Corp 相关性

10 最正相关
MMAC	0.897
NETE	0.869
AMRB	0.854
BOCH	0.838

10 最负相关
FEYE	-0.906
RMRM	-0.905
APOP	-0.88
SVAC	-0.875
TLGT	-0.869
SVOK	-0.865
PAIC	-0.863
SPRT	-0.825

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

SWK Holdings Corp 财务报表

Annual	2023
营收:	$37.76M
毛利润:	$34.32M (90.90 %)
EPS:	$1.260

FY	2023
营收:	$37.76M
毛利润:	$34.32M (90.90 %)
EPS:	$1.260

FY	2022
营收:	$41.48M
毛利润:	$34.53M (83.24 %)
EPS:	$1.050

FY	2021
营收:	$56.16M
毛利润:	$48.81M (86.92 %)
EPS:	$2.03

Financial Reports:

No articles found.

SWK Holdings Corp

SWK Holdings Corporation, a specialty finance company that focuses on the healthcare sector. It operates in two segments, Finance Receivables and Pharmaceutical Development. The company provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. It also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. In addition, the company engages in the pharmaceutical development, formulation and manufacturing, and licensing business through the Peptelligence platform. Further, it intends to out-license its internal product pipeline to create novel formulations using its proprietary technology to develop treatments for patients and caregivers. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was founded in 1996 and is headquartered in Dallas, Texas.